Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Cuprina Holdings (Cayman) LTD
Cuprina Holdings held an Extraordinary General Meeting of Shareholders on October 15, 2026, where shareholders approved an increase in the authorized share capital from $100,000 to $10,000,000. Additionally, the company adopted an amended Memorandum and Articles of Association to lower the voting threshold for written ordinary resolutions to a simple majority.…more
Cuprina Holdings (Cayman) LTD
Cuprina Holdings has entered into agreements to acquire Singapore-based healthcare group East Coast Podiatry and Orchard Clinic for approximately S$4.0 million (approx. US$3.1 million). The acquisition will be settled through a combination of cash and the issuance of new shares, with completion expected by November 1, 2026. The company intends to integrate its wound-care and collagen technologies into these clinical platforms to expand its business operations.…more
Cuprina Holdings (Cayman) LTD
Cuprina Holdings has raised an additional $745,629 through the full exercise of the underwriter's over-allotment option, issuing 648,373 Class A ordinary shares at $1.15 per share. This brings the total gross proceeds from the public offering to approximately $5,716,491, which the company intends to use for business expansion, R&D, and general corporate purposes.…more
14 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
Cuprina to Acquire Singapore Healthcare Group
Cuprina is acquiring seven podiatry and women's health clinics in Singapore for approximately $3.1 million. This acquisition serves as a strategic expansion to integrate the company's wound-care and collagen technologies into clinical practice.…more
●●●●●●●● ●●●●● ●●●●●●
Cuprina Holdings has completed the sale of additional shares following the full exercise of the underwriter’s over-allotment option. The proceeds will be utilized for business expansion, research and development, and general corporate purposes.…more
●●●●●●●● ●●●●● ●●●●●●
Biomedical company Cuprina Holdings has closed its public offering of Class A ordinary shares, raising approximately $4.97 million in gross proceeds. The company plans to utilize the funds for business expansion, R&D activities, and general corporate purposes.…more
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.